Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3 GBX | -14.29% | -14.29% | -25.00% |
Mar. 28 | EARNINGS AND TRADING: Arbuthnot ups payout as profit more than doubles | AN |
Mar. 20 | ReNeuron appoints administrators as rescue talks fail | AN |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 6.23M |
---|---|---|---|---|---|
Net income 2022 | -5M | Net income 2023 | -4M | EV / Sales 2022 | - |
Net cash position 2022 | 311K | Net cash position 2023 | 244K | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.89
x | P/E ratio 2023 |
-1.48
x | Employees | 4 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 75.46% |
1 day | -14.29% | ||
1 week | -14.29% | ||
Current month | -20.00% | ||
1 month | -20.00% | ||
3 months | -29.41% | ||
6 months | -33.33% | ||
Current year | -25.00% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Male
CEO | Chief Executive Officer | 56 | 21-05-31 |
David Robinson
DFI | Director of Finance/CFO | 41 | 20-01-31 |
Rory Kutluoglu
COO | Chief Operating Officer | - | 21-07-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Emma Priestley
BRD | Director/Board Member | 51 | 19-09-09 |
Paul Gurney
BRD | Director/Board Member | - | 22-04-13 |
Andrew Male
CEO | Chief Executive Officer | 56 | 21-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.3 | -14.29% | 2,634,622 |
24-03-27 | 0.35 | 0.00% | 247 |
24-03-26 | 0.35 | 0.00% | 865,750 |
24-03-25 | 0.35 | 0.00% | 438,667 |
24-03-22 | 0.35 | 0.00% | 1,539,037 |
Delayed Quote London S.E., March 28, 2024 at 12:35 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-25.00% | 2.3M | |
+23.76% | 82.35B | |
+10.45% | 67.45B | |
-.--% | 27.61B | |
+20.83% | 8.82B | |
+8.03% | 8.14B | |
-5.48% | 7.61B | |
-8.73% | 7.05B | |
+29.92% | 6.11B | |
+18.41% | 5B |